A new report shows 69% of DSOs expect to increase their acquisition activity this year, but fewer available practices could put a wrench in those plans. TUSK Practice Sales, a healthcare M&A advisory firm, released its “Dental Market Report” for the second quarter of 2026. TUSK reported seeing a wider variation of dental practice valuations […]
69% of DSOs Plan to Boost Acquisitions in 2026: Report Read More »
Invidia Capital Management, a healthcare investor founded in 2024, recently agreed to its first deal, which will give the firm a majority stake in fertility benefits and family services provider WIN, according to people familiar with the matter. The recently formed private-equity firm focused on healthcare is acquiring WIN from NexPhase Capital. Read the full
Invidia Capital Nears First Deal with Fertility and Family Services Provider Read More »
Achieve Partners announces the close of Achieve Partners Workforce II, a $450 million fund designed to respond to AI’s impact on the labor market and address talent shortages in the fastest-growing segments of the economy. Backed by institutional investment leaders including Cambridge Associates, JP Morgan Asset Management, Prudential, Ingka Investments, and ZOMA Capital, the new
Achieve Partners Closes $450M Fund Read More »
Marshall, Mo.-based Fitzgibbon Hospital has voluntarily filed for Chapter 11 bankruptcy protection as the independent rural hospital pursues a potential sale of the facility. The hospital said it has faced increasing financial pressures, including rising operating costs, workforce shortages and reimbursement at less than cost from government payers, according to an April 21 news release
Missouri Hospital Files for Bankruptcy, Pursues Sale Read More »
In the latest effort to stop healthcare fraud, Centers for Medicare & Medicaid Services Administrator Mehmet Oz, MD, on Thursday formally asked state Medicaid directors to develop and submit two-year provider revalidation strategies. Such strategies should include descriptions of how their respective state ensures the accuracy of provider enrollment data through revalidation and other approaches.
CMS Asks States to Submit Medicaid Provider Revalidation Strategies, Increase Oversight Read More »
The Centers for Medicare and Medicaid Services and the Food and Drug Administration have unveiled a new pathway to speed up Medicare coverage for certain breakthrough medical devices. The pathway, called the Regulatory Alignment for Predictable and Immediate Device, or RAPID, allows the two health agencies to work together, and with companies, during the device
CMS, FDA Unveil Speedier Medicare Coverage Pathway for Breakthrough Devices Read More »
U.S. Anesthesia Partners, Inc. (USAP) announces that it has reached an agreement in principle with the Federal Trade Commission (FTC) that, if finalized, would resolve the case brought by the FTC against USAP in Texas in September 2023. USAP Physician and Board Chairman Scott Holliday, DO, MBA, said that while USAP believes it has strong
USAP Reaches Agreement in Principle with Federal Trade Commission Read More »
TPG has completed the acquisition of Optum UK – the UnitedHealth Group subsidiary whose core asset is EMIS Group, the dominant supplier of electronic patient record systems to NHS general practices – with the transaction closing on March 13, 2026. Healthcare Dealflow identified TPG as the buyer through a review of regulatory filings. No press
Healthcare Dealflow: TPG Completes Acquisition of Optum UK from UnitedHealth Group Read More »
During the first quarter, UnitedHealth Group entered into an agreement to acquire Alegeus Technologies, a health care technology platform providing benefits administration for consumer-directed healthcare accounts, reflecting the company’s commitment to advancing more flexible, consumer-centered solutions. The acquisition is subject to regulatory review and is expected to close in the back half of 2026 and
UnitedHealth Group to Acquire Alegeus Technologies Read More »
Celerion, a global leader in clinical pharmacology and bioanalytical sciences, announces a majority investment from THL Partners (“THL”), a premier private equity firm investing in middle market growth companies. Celerion is a critical partner in bringing new medicines to market. The company is a premier provider of clinical pharmacology and advanced bioanalytical sciences, specializing in
Celerion Announces Majority Investment from THL Partners Read More »
